IL18 and acute pancreatitis: Disulfiram effectively suppressed the cleavage of GSDMD, ameliorated the development of caerulein‐induced severe acute pancreatitis (SAP) and the corresponding lung injury, and notably attenuated the expression levels of the pro‐inflammatory cytokines IL‐1β and IL‐18 [24].